Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Avicenna Journal of Medical Biotechnology|December 13, 2021
Fabrication of Calcium Sulfate Coated Selenium Nanoparticles and Corresponding <i>In-Vitro</i> Cytotoxicity Effects Against 4T1 Breast Cancer Cell LineElnaz Faghfuri, Ramak Ajideh, Faranak Shahverdi, et al.
Vaccines|January 21, 2023
Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic ReviewMina Hosseini, Simin Seyedpour, Behzad Khodaei, et al.
ACS Nano|July 9, 2026
A Buffered Hexacyanoferrate Electrolyte for Thermogalvanic Heat Harvesting across Symmetric and Asymmetric Electrode ConfigurationsMohammad Zakertabrizi, Ehsan Hosseini, Mina Hosseini, et al.
Journal of Drug Targeting|July 11, 2025
Boosting breast cancer immunotherapy through targeted siRNA delivery and sequential chemotherapyNaghmeh Jabarimani, Ehsan Khabazian, Bahar Morshedi, et al.
Journal of the American Geriatrics Society|February 9, 2017
Cognitive Differences between Men and Women who Fracture their Hip and Impact on Six-Month SurvivalAnn L Gruber-Baldini, Mina Hosseini, Denise Orwig, et al.
Neuroimmunomodulation|August 3, 2018
High Frequency of Tc22 and Th22 Cells in Myasthenia Gravis Patients and Their Significant Reduction after ThymectomyBehrouz Robat-Jazi, Mina Hosseini, Vahid Shaygannejad, et al.
Frontiers in Oncology|March 1, 2024
PX-478, an HIF-1α inhibitor, impairs mesoCAR T cell antitumor function in cervical cancerAhmad Reza Panahi Meymandi, Behnia Akbari, Tahereh Soltantoyeh, et al.
Journal of Cellular Biochemistry|January 21, 2017
Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future PerspectivesMina Hosseini, Seyed Mahdi Hassanian, Elham Mohammadzadeh, et al.
Neuroimmunomodulation|February 8, 2018
Increased Proportion of Tc17 and Th17 Cells and Their Significant Reduction after Thymectomy May Be Related to Disease Progression in Myasthenia GravisMina Hosseini, Behrouz Robat-Jazi, Vahid Shaygannejad, et al.
Current Protocols|August 21, 2024
Generation of Murine Chimeric Antigen Receptor-Modified T Cells for In Vivo Studies in Syngeneic Tumor ModelsMina Hosseini, Behnia Akbari, Ahmad Reza Shahverdi, et al.
Pageof 3